Proteomics International Laboratories Ltd (PIQ) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.132x

Based on the latest financial reports, Proteomics International Laboratories Ltd (PIQ) has a cash flow conversion efficiency ratio of -0.132x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-950.22K ≈ $-672.34K USD) by net assets (AU$7.21 Million ≈ $5.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Proteomics International Laboratories Lt (PIQ) balance sheet quality index to measure how much of total assets are equity-financed.

Proteomics International Laboratories Ltd - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Proteomics International Laboratories Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check PIQ cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Proteomics International Laboratories Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Proteomics International Laboratories Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Hindprakash Industries Limited NSE:HPIL	0.004x
Pearl Gold AG F:02P	N/A
Natural Health Trend NASDAQ:NHTC	-0.048x
Bertam Alliance Bhd KLSE:9814	-0.013x
Pasinex Resources Limited F:PNX	-0.047x
Artroniq Berhad KLSE:0038	0.001x
Panca Global Securities Tbk JK:PEGE	-0.129x
NYESA VALOS CO.EO 001 F:7NY0	N/A

Annual Cash Flow Conversion Efficiency for Proteomics International Laboratories Ltd (2014–2025)

The table below shows the annual cash flow conversion efficiency of Proteomics International Laboratories Ltd from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see Proteomics International Laboratories Lt market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$12.97 Million ≈ $9.18 Million	AU$-6.60 Million ≈ $-4.67 Million	-0.509x	+15.78%
2024-06-30	AU$9.25 Million ≈ $6.54 Million	AU$-5.59 Million ≈ $-3.96 Million	-0.605x	+11.59%
2023-06-30	AU$8.32 Million ≈ $5.89 Million	AU$-5.69 Million ≈ $-4.03 Million	-0.684x	+34.43%
2022-06-30	AU$3.39 Million ≈ $2.40 Million	AU$-3.54 Million ≈ $-2.50 Million	-1.043x	-259.29%
2021-06-30	AU$7.61 Million ≈ $5.38 Million	AU$-2.21 Million ≈ $-1.56 Million	-0.290x	-235.07%
2020-06-30	AU$4.44 Million ≈ $3.14 Million	AU$-384.51K ≈ $-272.06K	-0.087x	+84.48%
2019-06-30	AU$2.99 Million ≈ $2.11 Million	AU$-1.67 Million ≈ $-1.18 Million	-0.558x	-140.84%
2018-06-30	AU$4.68 Million ≈ $3.31 Million	AU$-1.08 Million ≈ $-766.91K	-0.232x	+74.63%
2017-06-30	AU$1.61 Million ≈ $1.14 Million	AU$-1.47 Million ≈ $-1.04 Million	-0.914x	+52.09%
2016-06-30	AU$791.42K ≈ $559.98K	AU$-1.51 Million ≈ $-1.07 Million	-1.907x	-408.33%
2015-06-30	AU$1.81 Million ≈ $1.28 Million	AU$-677.26K ≈ $-479.21K	-0.375x	-469.06%
2014-06-30	AU$4.94 Million ≈ $3.50 Million	AU$-325.72K ≈ $-230.47K	-0.066x	--

About Proteomics International Laboratories Ltd

AU:PIQ Australia Biotechnology

Market Cap

$15.78 Million

AU$22.30 Million AUD

Market Cap Rank

#25801 Global

#1138 in Australia

Share Price

AU$0.14

Change (1 day)

-6.90%

52-Week Range

AU$0.10 - AU$0.84

All Time High

AU$1.35